Cell therapy in corneal endothelial disease
EN Wong, JS Mehta - Current Opinion in Ophthalmology, 2022 - journals.lww.com
Cell therapy in corneal endothelial disease : Current Opinion in Ophthalmology Cell therapy in
corneal endothelial disease : Current Opinion in Ophthalmology Log in or Register Subscribe to …
corneal endothelial disease : Current Opinion in Ophthalmology Log in or Register Subscribe to …
Exploring Single-cell RNA sequencing as a decision-making tool in the clinical management of Fuchs' Endothelial Corneal Dystrophy
GN Yang, YBY Sun, PK Roberts, H Moka… - Progress in Retinal and …, 2024 - Elsevier
Single-cell RNA sequencing (scRNA-seq) has enabled the identification of novel gene
signatures and cell heterogeneity in numerous tissues and diseases. Here we review the …
signatures and cell heterogeneity in numerous tissues and diseases. Here we review the …
Fibrin gel enhanced trilayer structure in cell‐cultured constructs
Y Snyder, S Jana - Biotechnology and bioengineering, 2023 - Wiley Online Library
Efficient cell seeding and subsequent support from a substrate ensure optimal cell growth
and neotissue development during tissue engineering, including heart valve tissue …
and neotissue development during tissue engineering, including heart valve tissue …
Current state of endothelial cell therapy
EH Koo - Current Opinion in Ophthalmology, 2024 - journals.lww.com
Efficient and effective delivery of HCECs to patients with corneal edema and dysfunction
now appears feasible, and the results from ongoing human clinical trials are much …
now appears feasible, and the results from ongoing human clinical trials are much …
Comparative culture of human corneal endothelial cells following treatment with human platelet lysate/fibrin hydrogel versus Y-27632 ROCK inhibitor: in vitro and ex …
MA Mishan, S Balagholi, T Chamani, S Feizi… - International …, 2022 - Springer
Purpose The advancement of tissue engineering and cell therapy research has resulted in
innovative therapeutic options for patients with corneal endothelial diseases. The aim of this …
innovative therapeutic options for patients with corneal endothelial diseases. The aim of this …
The evolving therapeutics of endothelial disease
M Huertas-Bello, AL Sabater… - Eye Banking and Corneal …, 2023 - journals.lww.com
Endothelial dysfunction is one of the leading indications for corneal transplantation.
Globally, there is a shortage of donor corneas, which is partly because of the lack of eye …
Globally, there is a shortage of donor corneas, which is partly because of the lack of eye …
Regeneration of Volumetric Muscle Loss Using MSCs Encapsulated in PRP-Derived Fibrin Microbeads
Volumetric muscle loss (VML) is one of the major types of soft tissue injury frequently
encountered worldwide. In case of VML, the endogenous regenerative capacity of the …
encountered worldwide. In case of VML, the endogenous regenerative capacity of the …
[PDF][PDF] Optimiertes humanes Thrombozytenextrakt als Substituent für fetales Kälberserum in der kornealen Endothelzellkultur
L Reuland - 2023 - opus4.kobv.de
1. Hintergrund und Ziele In der Therapie der endothelialen Hornhauterkrankungen, wie
etwa der Fuchs 'schen Endotheldystrophie, gilt die Hornhauttransplantation und …
etwa der Fuchs 'schen Endotheldystrophie, gilt die Hornhauttransplantation und …
[PDF][PDF] Comparative culture of human corneal endothelial cells following treatment with human platelet lysate/fibrin hydrogel versus Y-27632 ROCK inhibitor: in vitro …
MAMSB Tahereh, CSFZS Soheili, MR Kanavi - researchgate.net
Purpose The advancement of tissue engineering and cell therapy research has resulted in
innovative therapeutic options for patients with corneal endothelial diseases. The aim of this …
innovative therapeutic options for patients with corneal endothelial diseases. The aim of this …